PMID- 28042305 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20201001 IS - 1741-427X (Print) IS - 1741-4288 (Electronic) IS - 1741-427X (Linking) VI - 2016 DP - 2016 TI - Vascular Contributions to Cognitive Impairment and Treatments with Traditional Chinese Medicine. PG - 9627258 LID - 10.1155/2016/9627258 [doi] LID - 9627258 AB - The prevalence of cognitive impairment and dementia caused by cerebrovascular disease is likely to increase with the global aging population. Vascular contributions to cognitive impairment and dementia (VCID) is a wide spectrum term used to include a diverse heterogeneous group of cognitive syndromes with vascular factors regardless of the cause of pathogenesis. VCID ranges from mild cognitive impairment to full-blown dementia with vascular dementia (VaD) as the most severe stage. It is further complexed by the coexistence of other forms of dementia such as Alzheimer's disease (AD). Recent researches in the functions of the neurovascular unit (NVU) suggest that dysfunction of the NVU might be the cause of primary vascular events in the brain that leads to further neurodegeneration. In this review, we have briefly summarized various forms of VCID. There is currently no standard therapy for VCID or dementia. Given the fact that Traditional Chinese Medicine (TCM) has gained popularity worldwide, we also reviewed recent scientific and clinical findings on various antidementia TCM for the treatment of VCID, including Salvia miltiorrhiza, Huperzia serrata, Ligusticum chuanxiong, Ginkgo biloba, Panax ginseng, and also TCM formula Sailuotong capsule (SLT) and Fufangdanshen tablets (FFDS). FAU - Zhou, Xinhua AU - Zhou X AD - State Key Laboratory of Quality Research in Chinese Medicine and Institute of Chinese Medical Sciences, University of Macau, Macau. FAU - Cui, Guozhen AU - Cui G AD - Department of Bioengineering, Zunyi Medical University, Zhuhai Campus, Guangdong, Zhuhai, China. FAU - Tseng, Hisa Hui Ling AU - Tseng HH AD - State Key Laboratory of Quality Research in Chinese Medicine and Institute of Chinese Medical Sciences, University of Macau, Macau. FAU - Lee, Simon Ming-Yuen AU - Lee SM AD - State Key Laboratory of Quality Research in Chinese Medicine and Institute of Chinese Medical Sciences, University of Macau, Macau. FAU - Leung, George Pak Heng AU - Leung GP AD - State Key Laboratory of Chinese Medicine and Molecular Pharmacology, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong. FAU - Chan, Shun Wan AU - Chan SW AUID- ORCID: 0000-0001-8238-798X AD - State Key Laboratory of Chinese Medicine and Molecular Pharmacology, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong; Department of Food and Health Sciences, Faculty of Science and Technology, Technological and Higher Education Institute of Hong Kong, Hong Kong. FAU - Kwan, Yiu Wa AU - Kwan YW AUID- ORCID: 0000-0002-9024-1275 AD - School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong. FAU - Hoi, Maggie Pui Man AU - Hoi MP AUID- ORCID: 0000-0003-2630-3707 AD - State Key Laboratory of Quality Research in Chinese Medicine and Institute of Chinese Medical Sciences, University of Macau, Macau. LA - eng PT - Journal Article PT - Review DEP - 20161123 PL - United States TA - Evid Based Complement Alternat Med JT - Evidence-based complementary and alternative medicine : eCAM JID - 101215021 PMC - PMC5141557 COIS- The authors declare that they have no competing interests. EDAT- 2017/01/04 06:00 MHDA- 2017/01/04 06:01 PMCR- 2016/11/23 CRDT- 2017/01/03 06:00 PHST- 2016/08/31 00:00 [received] PHST- 2016/10/12 00:00 [revised] PHST- 2016/10/18 00:00 [accepted] PHST- 2017/01/03 06:00 [entrez] PHST- 2017/01/04 06:00 [pubmed] PHST- 2017/01/04 06:01 [medline] PHST- 2016/11/23 00:00 [pmc-release] AID - 10.1155/2016/9627258 [doi] PST - ppublish SO - Evid Based Complement Alternat Med. 2016;2016:9627258. doi: 10.1155/2016/9627258. Epub 2016 Nov 23.